Single virions to study assembly of HIV-1
单一病毒体研究 HIV-1 的组装
基本信息
- 批准号:9459948
- 负责人:
- 金额:$ 33.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-05 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The productive site of HIV-1 assembly is the plasma membrane, both in cultured cell lines and primary cells. This conclusion is based both on the observation that newly synthesized Gag first appears at the plasma membrane, and is only detected later in endosomes, and the demonstration that inhibiting endocytosis blocks the appearance of virions in the internal organelles without affecting the yield of extracellular particles This assembly of HIV-1 at the plasma membrane make the assembly accessible to imaging using total internal reflection fluorescence microscopy (TIR-FM) a technique on which a large fraction of the experiments in this proposal are based. This technique has been used to visualize individual virions of HIV-1 as they assemble as well as the movement and packaging of individual molecules or dimers of HIV-1 genome. The technique has been used to demonstrate that the virions accumulate at the plasma membrane over a period of 6-20 minutes. The genome is recruited to the plasma membrane immediately before recruitment of Gag. In contrast, ESCRTs are recruited for only tens of seconds and tens of molecules transiently at the very end of the recruitment of Gag. The AAA-ATPase, Vps4, is recruited just seconds later. Super-resolution optical microscopy has added the information that ESCRT recruitment is to the neck that links the nascent virion to the mother cell. The long-term goal of this project is to identify, characterize and ultimately understand the steps in the biogenesis of HIV-1 and related retroviruses. We want to understand the dynamics of viral components as they interact with each other and with host components. Imaging based approaches allow the examination of both the dynamics and localization of molecules during which may be inaccessible through biochemical techniques. The main foci will be on the dynamics and localization of the viral protein Gag, the dynamics and localization of host molecules and then the relative dynamics and localization of the viral and host molecules.
描述(由申请人提供):在培养的细胞系和原代细胞中,HIV-1组装的生产力是质膜。这一结论既基于以下观察,即新合成的堵嘴首先出现在质膜上,并且只有在后期才检测到内体中,抑制内吞作用的证明会阻止内细胞器中病毒体在内部细胞器中的出现,而不会影响质体膜膜的内部反射率的纤维外粒子的产量,而不会影响质膜膜的内部含量,这是质膜膜膜膜的组合的产量。 (TIR-FM)该提案中大部分实验的技术。该技术已用于可视化HIV-1的单个病毒体,以及它们组装和包装HIV-1基因组的单个分子或二聚体的运动和包装。该技术已用于证明病毒体在6-20分钟内积聚在质膜上。募集GAG之前,该基因组将立即招募到质膜。相比之下,在募集GAG的末尾,将ESCRT募集仅数十秒和数十个分子。仅几秒钟后,AAA-ATPase VPS4被招募。超分辨率光学显微镜已将ESCRT募集的信息添加到将新生病毒粒子与母细胞联系起来的颈部。该项目的长期目标是识别,表征并最终了解HIV-1和相关逆转录病毒生物发生的步骤。我们想了解病毒组件相互交互以及与宿主组件相互作用时的动力学。基于成像的方法允许研究分子的动力学和定位,在此过程中,通过生化技术可能无法访问。主要灶将是关于病毒蛋白GAG的动力学和定位,宿主分子的动力学和定位,然后是病毒和宿主分子的相对动力学和定位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
SANFORD M SIMON的其他基金
Targeting the oncoprotein that drives FLC
靶向驱动 FLC 的癌蛋白
- 批准号:1090275110902751
- 财政年份:2023
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Center for therapeutic targeting of the Fusion Oncoprotein of Fibrolamellar Hepatocellular Carcinoma
纤维板层肝细胞癌融合癌蛋白治疗靶向中心
- 批准号:1082632310826323
- 财政年份:2023
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
ASO and shRNA for targeting the oncogenic transcript driving fibrolamellar hepatocellular carcinoma
ASO 和 shRNA 用于靶向驱动纤维层状肝细胞癌的致癌转录物
- 批准号:1065243210652432
- 财政年份:2020
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
ASO and shRNA for targeting the oncogenic transcript driving fibrolamellar hepatocellular carcinoma
ASO 和 shRNA 用于靶向驱动纤维层状肝细胞癌的致癌转录物
- 批准号:1017181410171814
- 财政年份:2020
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
ASO and shRNA for targeting the oncogenic transcript driving fibrolamellar hepatocellular carcinoma
ASO 和 shRNA 用于靶向驱动纤维层状肝细胞癌的致癌转录物
- 批准号:1041297110412971
- 财政年份:2020
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Center for therapeutic targeting of the Fusion Oncoprotein of Fibrolamellar Hepatocellular Carcinoma
纤维板层肝细胞癌融合癌蛋白治疗靶向中心
- 批准号:1022130810221308
- 财政年份:2019
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Single virions to study assembly of HIV-1
单一病毒体研究 HIV-1 的组装
- 批准号:92700409270040
- 财政年份:2016
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Cellular Pathogenesis of Fibrolamellar Hepatocellular Carcinoma
纤维板层肝细胞癌的细胞发病机制
- 批准号:91587449158744
- 财政年份:2016
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
The Center for HIV RNA Studies (CRNA)
HIV RNA 研究中心 (CRNA)
- 批准号:85128718512871
- 财政年份:2012
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Analysis of force developed by a AAA ATPase
AAA ATP酶产生的力分析
- 批准号:85368638536863
- 财政年份:2011
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
相似海外基金
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
- 批准号:1050830510508305
- 财政年份:2023
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Mechanisms of Metal Ion Homeostasis of Oral Streptococci
口腔链球菌金属离子稳态机制
- 批准号:1068095610680956
- 财政年份:2023
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Regulation of erythroid iron metabolism by the CLPX unfoldase
CLPX 解折叠酶对红细胞铁代谢的调节
- 批准号:1071649410716494
- 财政年份:2023
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Targeting Myosin to Treat Polycystic Kidney Disease
靶向肌球蛋白治疗多囊肾
- 批准号:1069985910699859
- 财政年份:2023
- 资助金额:$ 33.48万$ 33.48万
- 项目类别:
Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
- 批准号:1056872310568723
- 财政年份:2023
- 资助金额:$ 33.48万$ 33.48万
- 项目类别: